Akari Therapeutics Plc

(AKTX) Trade

By |

Profile

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing inhibitors of acute and chronic inflammation which includes the complement system, the bioamine system and the eicosanoid system for the treatment of rare and orphan diseases. Its main product candidate includes Coversin, Coversin long acting and Coversin dual action. The firm earns majority of its revenues from United Kingdom. It operates mainly in United States and United Kingdom.

Contact Information

Website: www.akaritx.com
Email: peter.vozzo@westwicke.com
Main Phone: +44 2080040270
Address: 75/76 Wimpole Street
Address 2: 8th Floor
State: NY
City / Town: London
Country: GBR
Postal Code: W1G 9RT

Issuer Information

Exchange: NSC
CEO: Clive Richardson
Employees: 17
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 1.82 $ 0.0453 (2.56%)
Last Price 1.82 Change $ 0.0453 Change % 2.56 Tick N/A
Bid 1.71 Bid Size 100.00 Ask 2.86 Ask Size 100.00
Open 1.76 High 1.85 Low 1.76 Prev Close 1.77
Last Trade Volume 5,267 52 Wk Hi 4.89 52 Wk Low 1.62
Market Cap 27.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 15,256,934.00 EPS (TTM) -2.32 PE Ratio N/A Exchange NCM
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 8 8 8 8
Low Target Price Estimate 2.5 2.5 2.5 2.5
Mean Target Price Estimate 5.25 5.25 5.25 5.25
Standard Deviation 3.89 3.89 3.89 3.89
Date of Most Recent Estimate 03/29/18 03/29/18 03/29/18 03/29/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 2 2 1
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2 1.67 1.67 2